跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 哲玄
副教授
,
耳鼻喉學科
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北神經醫學中心
https://orcid.org/0000-0001-9134-3786
電子郵件
d119105002
tmu.edu
tw
h-index
253
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2025
每年研究成果
概覽
指紋
網路
專案
(5)
研究成果
(32)
類似的個人檔案
(6)
指紋
查看啟用 Che-Hsuan Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Upregulation
100%
Autophagy
86%
Radiosensitivity
76%
Cancer Cell
43%
down Regulation
36%
Cell Death
36%
Luciferase
34%
Survival Rate
34%
E2F
33%
P53
29%
Messenger RNA
25%
Mammalian Target of Rapamycin
25%
Immune Checkpoints
25%
Tumor Progression
24%
STAT1
22%
Cell Invasion
22%
IC50
21%
Reverse Transcription Polymerase Chain Reaction
21%
Autophagosome
20%
Visual Acuity
18%
TXNIP
18%
Progression Free Survival
18%
CHRNA5
18%
Precursor
18%
Illumination
18%
Drive
18%
Inositol Monophosphatase
18%
Alpha Chain
18%
Guanylate-Binding Protein
18%
Nicotinic Acetylcholine Receptor
18%
DNA Polymerase
18%
Phospholipase C
18%
Histone H2A
18%
MicroRNA
18%
Palmitoylation
18%
Interleukin 8
18%
Thyroglobulin
18%
Doxorubicin
18%
Gene Set Enrichment Analysis
17%
Cell Migration
13%
Western Blot
12%
Anthracycline
11%
Computer Model
9%
Cytotoxic Concentration
9%
Inflammasome
9%
Cell Proliferation
9%
Biological Activity
9%
Next Generation Sequencing
9%
Anticancer
7%
STAT3
7%
Medicine and Dentistry
Upregulation
44%
Nodular Melanoma
36%
Programmed Cell Death
36%
Mouth Squamous Cell Carcinoma
36%
Systematic Review
36%
Meta-Analysis
36%
Otorhinolaryngology
33%
Radiosensitivity
28%
Malignant Neoplasm
24%
Fine-Needle Aspiration
24%
Oral Cancer
20%
Clear Cell Renal Cell Carcinoma
18%
down Regulation
18%
Absence
18%
Visual Acuity
18%
Lung Adenocarcinoma
18%
Inositol
18%
Autophagy
18%
Ovarian Cancer
18%
Hearing Impairment
18%
Bone Conduction
18%
Glioblastoma
18%
Temozolomide
18%
STAT1 Protein
18%
Guanine Nucleotide Binding Protein
18%
Programmed Death 1 Ligand 1
18%
Paclitaxel
18%
Histone H2A
18%
Echography
18%
Medicine
18%
Sialolithiasis
18%
Voice Therapy
18%
Paralysis
18%
Voice
18%
Vocal Folds
18%
Paraneoplastic Pemphigus
18%
Palmitoylation
18%
Lymph Node
18%
Real-World Data
18%
Cleft Lip Palate
18%
Paresthesia
18%
Dental Scaling
18%
Thyroglobulin
18%
Goiter
18%
Secretory Otitis Media
18%
Head and Neck Cancer
18%
Retrospective Study
18%
Palatoplasty
18%
Retrospective Cohort Study
18%
Arm
18%
Pharmacology, Toxicology and Pharmaceutical Science
Renal Cell Carcinoma
36%
Mouth Squamous Cell Carcinoma
36%
Triple Negative Breast Cancer
36%
Paclitaxel
31%
Biological Marker
28%
Infection
18%
Mouse
18%
Rhus
18%
Inositol
18%
Mouth Cancer
18%
Ovary Cancer
18%
Docetaxel
18%
Ferrous Ion
18%
Castration Resistant Prostate Cancer
18%
Gallic Acid
18%
Lactoferrin
18%
STAT1 Protein
18%
Melanoma
18%
Programmed Cell Death
18%
Guanine Nucleotide Binding Protein
18%
Programmed Death 1 Ligand 1
18%
Sialolithiasis
18%
DNA Polymerase
18%
Prevalence
18%
Sleep Disordered Breathing
18%
Phosphotransferase
18%
Retina S Antigen
18%
Mitogen Activated Protein Kinase 1
18%
Receptor
18%
Mucosa Inflammation
18%
Chlorogenic Acid
18%
Fluorouracil
18%
IC50
12%
Immune Checkpoint Inhibitor
12%
Antioxidant
11%
Luciferase
10%
Chemotherapy
10%
Malignant Neoplasm
10%
Mammalian Target of Rapamycin Inhibitor
8%
Western Blot
7%
Acetic Acid Ethyl Ester
7%
Metastasis Potential
7%
Sialoadenitis
6%
Primary Tumor
5%
Protein P53
5%
